Phibro Animal Health Corporation PAHC

34.45 0.52 1.53% as of 25 Sep
Market cap
$1.4B
P/E
14.0×
Growth Flags show if company had growth for consecutive years,
Insider Buys alert about insiders buying in the last 12 month

An Income Statement, also known as a Profit and Loss Statement, summarizes a company's revenues, expenses, and profits over a specific period. It highlights how revenue is transformed into net income, showcasing operational efficiency. Key components include total revenue, cost of goods sold (COGS), gross profit, operating expenses, and net profit. Businesses use the Income Statement to assess financial performance, make strategic decisions, and ensure profitability. Investors and stakeholders analyze it to gauge the company’s financial health and future growth potential.

Jun '17 Jun '18 Jun '19 Jun '20 Jun '21 Jun '22 Jun '23 Jun '24 Jun '25 Jun '26
Revenue
764.28 819.98 828.00 800.35 833.35 942.26 977.89 1,017.68 1,296.22 1,518.09
Revenue Growth
1.70% 7.29% 0.98% (3.34%) 4.12% 13.07% 3.78% 4.07% 27.37% 17.12%
Cost of Revenue
516.04 553.10 563.37 543.47 561.97 656.86 679.65 704.59 896.27 1,005.58
Gross Profit
248.24 266.88 264.62 256.88 271.38 285.40 298.24 313.09 399.94 512.52
SG&A Expenses
150.31 167.95 181.40 187.69 196.51 206.41 226.39 259.78 289.48 318.12
Operating Income
97.93 98.93 83.23 69.19 74.87 78.99 71.85 53.32 110.47 194.40
Non-operating Income/Expense
(17.39) (10.86) (11.72) (13.68) (8.40) (6.66) (17.78) (42.40) (42.47) (57.05)
Non-operating Interest Expenses
14.91 11.91 11.78 12.86 12.88 11.88 15.32 18.54 34.60 44.43
EBT
80.54 88.07 71.51 55.51 66.47 72.33 54.07 10.92 67.99 137.35
Income Tax Provision
15.93 23.19 16.79 21.96 12.08 23.15 21.47 8.50 19.73 37.63
Income after Tax
64.62 64.88 54.71 33.55 54.39 49.18 32.61 2.42 48.26 99.72
Dividends (Preferred)
— 0.00 0.00 0.00 0.00 0.00 — 0.00 0.00 0.00
Net Income Common
64.62 64.88 54.71 33.55 54.39 49.18 32.61 2.42 48.26 99.72
EPS (Basic)
1.63 1.61 1.35 0.83 1.34 1.21 0.81 0.06 1.19 2.46
EPS (Diluted)
1.61 1.61 1.35 0.83 1.34 1.21 0.81 0.06 1.19 2.43
Shares (Basic, Weighted)
39.52 40.18 40.41 40.45 40.47 40.50 40.50 40.50 40.52 40.55
Shares (Diluted, Weighted)
40.04 40.39 40.52 40.50 40.50 40.50 40.50 40.52 40.68 40.96
Gross Margin
32.48% 32.55% 31.96% 32.10% 32.56% 30.29% 30.50% 30.77% 30.85% 33.76%
EBIT Margin
12.81% 12.06% 10.05% 8.65% 8.98% 8.38% 7.35% 5.24% 8.52% 12.81%
EBT margin
10.54% 10.74% 8.64% 6.94% 7.98% 7.68% 5.53% 1.07% 5.25% 9.05%
Net Profit Margin
8.45% 7.91% 6.61% 4.19% 6.53% 5.22% 3.33% 0.24% 3.72% 6.57%
Free Cash Flow Margin
10.14% 6.28% 2.09% 3.16% 2.28% (0.57%) (3.94%) 4.56% 3.23% 0.65%
EBITDA
124.95 126.75 111.67 102.42 107.59 112.28 106.59 90.53 158.09 248.23
EBIT
97.93 98.93 83.23 69.19 74.87 78.99 71.85 53.32 110.47 194.40
Income from Continuous Operations
64.62 64.88 54.71 33.55 54.39 49.18 32.61 2.42 48.26 99.72
Consolidated Net Income/Loss
64.62 64.88 54.71 33.55 54.39 49.18 32.61 2.42 48.26 99.72
EPS (Basic, from Continuous Ops)
1.63 1.61 1.35 0.83 1.34 1.21 0.81 0.06 1.19 2.46
EPS (Basic, Consolidated)
1.63 1.61 1.35 0.83 1.34 1.21 0.81 0.06 1.19 2.46
EPS (Diluted, from Cont. Ops)
1.61 1.61 1.35 0.83 1.34 1.21 0.81 0.06 1.19 2.43
Shares (Diluted, Average)
40.00 40.40 40.50 40.50 40.50 40.50 40.50 40.52 40.68 41.00
EPS (Diluted, Consolidated)
1.61 1.61 1.35 0.83 1.34 1.21 0.81 0.06 1.19 2.43
EBITDA Margin
16.35% 15.46% 13.49% 12.80% 12.91% 11.92% 10.90% 8.90% 12.20% 16.35%
Operating Cash Flow Margin
12.87% 8.54% 5.70% 7.42% 5.80% 3.36% 1.36% 8.61% 6.18% 4.54%

Fold the line items

In millions of $ except per-share values · columns are period end dates